Genomics Essentials in Hematologic Malignancies
Podcast Episodes
This series of six, 15-minute podcast episodes feature faculty from academic and community oncology settings who will shed light on the importance of genomics to the diagnosis, risk stratification, and prognosis, as well as disease monitoring and therapeutic decision-making in hematologic malignancies.
Release Date: June 21, 2023
Episode Topics
Dr. Michael Diaz and Dr. Emily K. Curran discuss the importance of genomic testing and how to understand and interpret test results when treating patients with acute lymphoblastic leukemia (ALL). They also discuss the importance of selecting appropriate therapeutic agents to manage hematologic malignancies.
Speakers
Michael Diaz, MD
Florida Cancer Specialists & Research Institute
St. Petersburg, FL
Emily K. Curran, MD
University of Cincinnati
Cincinnati, OH
Dr. Michael Diaz and Dr. James Blachly discuss the importance of genomic testing and how to understand and interpret test results when treating patients with acute myeloid leukemia (AML). They also discuss the importance of selecting appropriate therapeutic agents to manage hematologic malignancies.
Speakers
Michael Diaz, MD
Florida Cancer Specialists & Research Institute
St. Petersburg, FL
James Blachly, MD
The Ohio State University
Columbus, OH
Dr. Sanjay Juneja and Dr. Jacqueline Barrientos discuss the importance of genomic testing and how to understand and interpret test results when treating patients with chronic lymphocytic leukemia (CLL). They also discuss the importance of selecting appropriate therapeutic agents to manage hematologic malignancies.
Speakers
Sanjay Juneja, MD (@TheRealOncDoc)
Mary Bird Perkins Cancer Center
Baton Rouge, LA
Jacqueline Barrientos, MD, MS
Mount Sinai Medical Center
Miami, FL
Dr. Sanjay Juneja and Dr. David Russler-Germain discuss the importance of genomic testing and how to understand and interpret test results when treating patients with lymphoma. They also discuss the importance of selecting appropriate therapeutic agents to manage hematologic malignancies.
Speakers
Sanjay Juneja, MD (@TheRealOncDoc)
Mary Bird Perkins Cancer Center
Baton Rouge, LA
David Russler-Germain, MD, PhD
Washington University School of Medicine
St. Louis, MO
Dr. Michael Diaz and Dr. Namrata Chandhok discuss the importance of genomic testing and how to understand and interpret test results when treating patients with myelodysplastic syndromes (MDS) and clonal hematopoiesis. They also discuss the importance of selecting appropriate therapeutic agents to manage hematologic malignancies.
Speakers
Michael Diaz, MD
Florida Cancer Specialists & Research Institute
St. Petersburg, FL
Namrata Chandhok, MD
University of Miami Health System
Miami, FL
Dr. Sanjay Juneja and Dr. Ajai Chari discuss the importance of genomic testing and how to understand and interpret test results when treating patients with myeloma. They also discuss the importance of selecting appropriate therapeutic agents to manage hematologic malignancies.
Speakers
Sanjay Juneja, MD (@TheRealOncDoc)
Mary Bird Perkins Cancer Center
Baton Rouge, LA
Ajai Chari, MD
Mount Sinai Cancer Clinical Trials Office
New York, NY
Target Audience
These podcasts are intended for hematologists, hematologists/oncologists, medical oncologists, physician assistants, nurse practitioners, and nurses who care for patients with blood cancers.
Learning Objectives
Upon completion of the activity, participants should be able to:
- Review genomic principles, terminology, technologies, and applications
- Describe available genomic tests for diagnosis of hematologic malignancies and relevant premalignant conditions
Providers
This activity is provided by The Leukemia & Lymphoma Society and the American Society of Hematology in collaboration with The France Foundation.
Supporters
This activity is supported by educational grants from AbbVie, Astellas, Daiichi Sankyo, Illumina, and Pharmacyclics.